MindWalk Holdings (HYFT) Inventory (2020 - 2026)
MindWalk Holdings (HYFT) posted quarterly Inventory of $358917.0 for Q2 2026, down 75.62% year-over-year from $1.5 million in Q2 2025, and up 1.65% quarter-over-quarter from $353079.2 in Q1 2026.
MindWalk Holdings (HYFT) Inventory (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Inventory for 7 consecutive years, with $358917.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Inventory fell 75.62% year-over-year to $358917.0; the TTM figure through Apr 2026 stood at $358917.0 (down 75.62% YoY), while the FY2026 annual figure was $358917.0, down 76.14% from the prior year.
- Inventory grew to $358917.0 in Q2 2026 per HYFT's latest filing, from $353079.2 in the prior quarter.
- Across five years, Inventory topped out at $1.9 million in Q1 2024 and bottomed at $353079.2 in Q1 2026.
- Historically, Inventory has averaged $1.2 million across 5 years, with a median of $1.3 million in 2023.
- Annual changes were most pronounced in 2023 — Inventory jumped 51.54% — and 2026, when it plunged 75.62%.
- MindWalk Holdings' Inventory stood at $1.2 million in 2022, then surged by 51.54% to $1.8 million in 2023, then retreated by 18.6% to $1.5 million in 2024, then sank by 73.99% to $382786.8 in 2025, then dropped by 6.24% to $358917.0 in 2026.
- Business Quant data shows HYFT's Inventory at $358917.0 in Q2 2026, $353079.2 in Q1 2026, and $382786.8 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 358,916.96 |
| Jan 31, 2026 | 353,079.15 |
| Oct 31, 2025 | 382,786.75 |
| Jul 31, 2025 | 381,359.51 |
| Apr 30, 2025 | 1.47 Mn |
| Jan 31, 2025 | 1.35 Mn |
| Oct 31, 2024 | 1.47 Mn |
| Jul 31, 2024 | 1.36 Mn |
| Apr 30, 2024 | 1.58 Mn |
| Jan 31, 2024 | 1.87 Mn |
| Oct 31, 2023 | 1.81 Mn |
| Jul 31, 2023 | 1.66 Mn |
| Apr 30, 2023 | 1.52 Mn |
| Jan 31, 2023 | 1.34 Mn |
| Oct 31, 2022 | 1.19 Mn |
| Jul 31, 2022 | 1.20 Mn |
| Apr 30, 2022 | 1.28 Mn |
| Jan 31, 2022 | 1.21 Mn |
| Oct 31, 2021 | 1.02 Mn |
| Jul 31, 2021 | 1.05 Mn |